Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs9878464 | chr3:136586506 | C/G | 0.000479 | 178 | 24.37 | 27.33 | 25.17 | KM Plot |
PCPG | rs9880479 | chr3:39237475 | A/G | 3.99E-7 | 175 | 21.98 | 25.53 | 25.28 | KM Plot |
PCPG | rs9883980 | chr3:80470996 | C/T | 0.000387 | 178 | 25.47 | 25.92 | 19.53 | KM Plot |
PCPG | rs9892353 | chr17:74704522 | G/A | 0.000173 | 175 | 25.97 | 14.63 | 13.5 | KM Plot |
PCPG | rs9898569 | chr17:80493953 | C/T | 4.82E-5 | 176 | 25.87 | 22.33 | 7.2 | KM Plot |
PCPG | rs9900949 | chr17:74698565 | G/A | 0.000171 | 177 | 26.27 | 17.1 | 13.5 | KM Plot |
PCPG | rs9909030 | chr17:75718552 | A/G | 4.17E-11 | 178 | 5.15 | 22.88 | 25.6 | KM Plot |
PCPG | rs9910053 | chr17:74667807 | A/C | 1.31E-6 | 171 | 25.4 | 24.88 | 10.28 | KM Plot |
PCPG | rs9912538 | chr17:80482018 | C/T | 4.46E-5 | 177 | 25.92 | 19.72 | 7.2 | KM Plot |
PCPG | rs991333 | chr3:80575616 | T/G | 6.94E-5 | 176 | 19.53 | 24.53 | 27.2 | KM Plot |
PCPG | rs9922608 | chr16:1693614 | G/A | 0 | 178 | 25.47 | 18.2 | 2.93 | KM Plot |
PCPG | rs9922630 | chr16:1723065 | C/G | 0 | 178 | 25.53 | 18.75 | 2.93 | KM Plot |
PCPG | rs9924715 | chr16:1676288 | C/T | 5.51E-5 | 176 | 25.28 | 22.77 | 19.83 | KM Plot |
PCPG | rs9925164 | chr16:1714749 | T/C | 0 | 178 | 25.53 | 18.75 | 2.93 | KM Plot |
PCPG | rs9925938 | chr16:1689227 | G/T | 0 | 178 | 25.4 | 22.77 | 2.93 | KM Plot |